Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN-627 in Non-Active Progressive Multiple Sclerosis
NCT07840326Phase 2Recruiting
- Sponsor
- Sundance Biosciences
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SUN-627 in primary progressive multiple sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), sponsored by Sundance Biosciences. Started Oct 2026; status: recruiting.
02
Drugs
SUN-627
03
Conditions
primary progressive multiple sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT07840326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07840326.